Form 4 holding
Director, 10%+ Owner
Kailera Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 22,583,268
- Estimated value
- Report date
- 20 Apr 2026
- Price
- Ownership
- Indirect
Adam Koppel - Director, 10%+ Owner at Kailera Therapeutics, Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- Director, 10%+ Owner
- Issuer symbol
- KLRA on Nasdaq
- Source filings
- Open source filing history
There are no Buy or Sell transactions made by Adam Koppel since 30 May 2025
Holdings reported by Adam Koppel for Kailera Therapeutics, Inc.
Form 4 holding
Director, 10%+ Owner
Kailera Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 38,300
- Estimated value
- Report date
- 16 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Kailera Therapeutics, Inc.
- Security class
- Series A-1 Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 20 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Kailera Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 20 Apr 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Adam Koppel for Kailera Therapeutics, Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
An asterisk next to the price means the reported price is likely invalid.